esmolol has been researched along with Diabetes Mellitus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deshpande, SK; Kulkarni, SA; Rastogi, A | 1 |
| Agarwal, S; Akhtar, M; Arsule, S; Bhamre, S; Bhosle, D; Darivemula, AK; Desai, S; Deshmukh, M; Deshpande, SK; Giriraja, KV; Jagannath, J; Kashiva, RY; Kesavan, R; Khandelwal, D; Kolte, S; Kongara, S; Kulkarni, SA; Madhusudan, C; Pyare Saheb Qureshi, MAH; Ramu, M; Rastogi, A; Rathod, G; Shakya, S; Shetty, P; Singh, S; Unnikrishnan, AG; Viswanathan, V; Yalamanchi, SR | 1 |
1 trial(s) available for esmolol and Diabetes Mellitus
| Article | Year |
|---|---|
Topical Esmolol Hydrochloride as a Novel Treatment Modality for Diabetic Foot Ulcers: A Phase 3 Randomized Clinical Trial.
Topics: Adult; Diabetes Mellitus; Diabetic Foot; Humans; India; Male; Middle Aged; Standard of Care; Wound Healing | 2023 |
1 other study(ies) available for esmolol and Diabetes Mellitus
| Article | Year |
|---|---|
Novel topical esmolol hydrochloride improves wound healing in diabetes by inhibiting aldose reductase, generation of advanced glycation end products, and facilitating the migration of fibroblasts.
Topics: Aldehyde Reductase; Animals; Diabetes Complications; Diabetes Mellitus; Endothelial Cells; Fibroblasts; Glucose; Glycation End Products, Advanced; Humans; Hydroxyproline; Nitric Oxide; Propanolamines; Rats; Sorbitol; Streptozocin; Swine; Swine, Miniature; Wound Healing | 2022 |